Welcome to ZEEVIEZEE BIO PHARMA

Advancing Science for Better Health

Enabling the development and manufacture of next-generation therapeutics through integrated science, advanced technologies, and global expertise.
We are a trusted partner to pharmaceutical and biotech companies, delivering end-to-end solutions across the drug lifecycle—from early development to commercial manufacturing. Our focus on innovation, quality, and scalability helps bring life-changing medicines to patients worldwide.

Our Company

Fastest Growing Bio Pharma Company

A team of senior scientists with highly sophisticated research labaratory at zeeviezee bio pharma focused on formulation R&D, API R&D, manufacturing of new pharmaceuticals & in collaboration with the world class pharma companies with CDMO and CRAMS to achieve the vision of the company for better life of the mankind.

“Pharmaceutical research is not merely the pursuit of new medicines; it is the pursuit of better possibilities for human life—transforming scientific discovery into solutions that serve humanity.”

ZeeVieZee Biopharma Team.

Our Values

Driven by values. Guided by science. Committed to better health.

01.

Innovation

We are driven by innovation that transforms scientific ideas into meaningful healthcare solutions. Our focus is on the development of new APIs, advanced formulations, and innovative drug-delivery approaches that aim to improve therapeutic outcomes and enhance quality of life.

Through our CDMO and CRAMS capabilities, we collaborate with pharmaceutical and biotechnology companies to accelerate research, development, and commercialization. From early-stage development to scale-up and manufacturing, we combine scientific expertise, quality, and technology to deliver reliable, patient-focused solutions.

02.

Compliance under the regulatory requirements

We are committed to maintaining the highest standards of regulatory compliance, quality, and integrity across our API and formulation development activities. Our processes are designed to align with applicable global regulatory requirements, Good Manufacturing Practices (GMP), and quality standards throughout the product lifecycle.

From R&D and analytical development to CDMO and CRAMS services, we prioritize robust documentation, data integrity, quality systems, and regulatory readiness. Our commitment to compliance helps ensure that every solution we develop meets stringent quality expectations while supporting the safe, effective, and timely advancement of healthcare products.

03.

Sustainable

We are committed to advancing sustainable innovation in the biopharmaceutical industry by developing new APIs, formulations, and drug-delivery solutions with a focus on efficiency, quality, and responsible resource utilization.

Through our CDMO and CRAMS services, we strive to integrate sustainable practices across research, development, manufacturing, and scale-up activities. By reducing waste, optimizing processes, and promoting responsible use of resources, we aim to create lasting value for our partners, patients, and the environment.

Advancing healthcare responsibly, today and for generations to come.

04.

Integrity

We believe integrity is the foundation of trust, scientific excellence, and responsible innovation. We conduct our API and formulation development activities with transparency, honesty, accountability, and respect for ethical and regulatory standards.

Across our CDMO and CRAMS services, we are committed to maintaining data integrity, protecting confidentiality, and delivering on our commitments with consistency and professionalism. By doing the right thing at every stage, we build trusted partnerships and contribute to the development of safe, effective, and high-quality healthcare solutions.

05.

Excellence

We are committed to excellence in science, quality, and execution across every stage of API and formulation development. Our approach combines scientific expertise, advanced technologies, and rigorous quality standards to deliver innovative and reliable solutions that improve patient outcomes.

Through our CDMO and CRAMS capabilities, we continuously strive to enhance processes, accelerate development, and exceed expectations while maintaining the highest standards of quality, compliance, and performance.

Pursuing excellence in every molecule, formulation, and partnership.

06.

Commitment

We are committed to transforming scientific innovation into better healthcare solutions through the development of new APIs, advanced formulations, and innovative drug-delivery technologies. We approach every project with dedication, scientific rigor, and a clear focus on quality and patient needs.

Through our CDMO and CRAMS services, we work closely with our partners to support their development journey—from research and formulation development to scale-up and manufacturing. Our commitment is to deliver consistent quality, reliable timelines, regulatory readiness, and long-term value at every stage.

Committed to science. Committed to quality. Committed to better health.

Our Products

Committed to Quality

We are dedicated to creating innovative, reliable, and sustainable healthcare solutions that improve lives and build a healthier future.

Our commitment to innovation extends from proprietary intellectual property and patented technologies to clinical development. We advance promising new APIs and innovative formulations through scientifically driven clinical programs designed to evaluate their safety, efficacy, and therapeutic potential.

Our proprietary pipeline is supported by robust R&D, regulatory expertise, and quality-driven development processes. Alongside our own innovative programs, our CDMO and CRAMS capabilities enable partners to accelerate clinical development through integrated research, formulation, analytical, and development support.

From intellectual property to clinical innovation, we strive to transform promising science into better healthcare solutions.

We support the journey from scientific innovation to global regulatory access, enabling the development of new APIs and advanced formulations for regulated markets. Our approach integrates regulatory strategy, quality systems, scientific documentation, and development expertise to help meet evolving regulatory expectations.

Through our CDMO and CRAMS services, we work with partners to facilitate regulatory-ready development, supporting activities across analytical development, formulation development, scale-up, technology transfer, and manufacturing.

Connecting innovative science with regulatory pathways to bring better healthcare solutions to patients worldwide.

We harness biotechnology and scientific innovation to develop next-generation APIs, advanced formulations, and novel therapeutic solutions that address evolving healthcare needs. Our approach combines research expertise, modern technologies, and quality-driven development to translate promising scientific concepts into practical healthcare solutions.

Through our CDMO and CRAMS capabilities, we collaborate with pharmaceutical and biotechnology companies to support their development programs—from early-stage research and formulation development to analytical development, scale-up, and manufacturing.

Advancing biotechnology through science, innovation, and purpose to create better solutions for life.

We provide specialized functional services across the pharmaceutical development lifecycle, supporting the development of new APIs, advanced formulations, and innovative drug-delivery solutions. Our integrated expertise spans analytical development, formulation development, process development, quality, regulatory support, technology transfer, and scale-up.

Through our CDMO and CRAMS capabilities, we offer flexible, science-driven solutions tailored to the specific needs of our partners. By combining technical expertise, quality systems, and efficient project execution, we help accelerate development and bring innovative healthcare solutions closer to patients.

Specialized expertise. Integrated solutions. Accelerated development.

Our Purpose

Innovating with purpose. Developing for life.

“We combine scientific expertise, innovation, and quality to develop advanced healthcare solutions that create meaningful value for patients and our partners.”

Our purpose is to advance science into meaningful healthcare solutions that improve and enrich lives. We strive to discover and develop new APIs, innovative formulations, and advanced drug-delivery solutions while supporting pharmaceutical and biotechnology partners through our CDMO and CRAMS capabilities.

By combining scientific innovation, quality, integrity, and collaboration, we aim to accelerate the journey from research and development to reliable, accessible healthcare solutions for patients around the world.